Immune Modulation by Exosomes in COVID-19
Immune Modulation by Exosomes in COVID-19
Recruiting · NCT05191381 · Registry updated 2024-01-17Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Immune Modulation by Exosomes in COVID-19 | COVID-19, Coronaviridae Infections, Critical Illness, Disease Attributes, Fibrosis, Infections, Inflammation, Nidovirales infectious disease, Orthocoronavirinae infectious disease, Pathologic Processes, Pathological Conditions, Signs and Symptoms, RNA Virus Infections, Sepsis, Shock, Systemic Inflammatory Response Syndrome, cytokine release syndrome, interstitial lung disease, lung disorder, pneumonia, pulmonary fibrosis, respiratory system disorder, respiratory tract infectious disorder, viral infectious disease, viral pneumonia | Recruiting | Not stated | 2024-01-17 | NCT05191381 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| University of Ulm | 46 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Ulm University Hospital, Clinic of Anesthesiology and Intensive Care Medicine | Ulm | Germany | 1 |